de Brian C. Broderick AbbVie ABBV Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 3.53 M | Comprar |
14,011
+180
| +1% | +USD 38.7 k | 0.55% | 40 |
|
|
2026
Q1 | USD 3.01 M | Comprar |
13,831
+506
| +4% | +USD 112 k | 0.55% | 40 |
|
|
2025
Q4 | USD 3.04 M | Vender |
13,325
-45
| -0.3% | -USD 10.3 k | 0.58% | 39 |
|
|
2025
Q3 | USD 3.1 M | Comprar |
13,370
+304
| +2% | +USD 61.9 k | 0.59% | 37 |
|
|
2025
Q2 | USD 2.43 M | Vender |
13,066
-12
| -0.1% | -USD 2.23 k | 0.48% | 42 |
|
|
2025
Q1 | USD 2.74 M | Vender |
13,078
-25
| -0.2% | -USD 4.86 k | 0.56% | 39 |
|
|
2024
Q4 | USD 2.33 M | Mantener |
13,103
| – | – | 0.46% | 40 |
|
|
2024
Q3 | USD 2.59 M | Vender |
13,103
-20
| -0.2% | -USD 3.73 k | 0.51% | 42 |
|
|
2024
Q2 | USD 2.25 M | Comprar |
13,123
+511
| +4% | +USD 84.6 k | 0.46% | 45 |
|
|
2024
Q1 | USD 2.3 M | Comprar |
12,612
+1,673
| +15% | +USD 288 k | 0.49% | 40 |
|
|
2023
Q4 | USD 1.7 M | Vender |
10,939
-1,258
| -10% | -USD 183 k | 0.42% | 41 |
|
|
2023
Q3 | USD 1.82 M | Vender |
12,197
-70
| -0.6% | -USD 10.3 k | 0.5% | 40 |
|
|
2023
Q2 | USD 1.65 M | Mantener |
12,267
| – | – | 0.44% | 41 |
|
|
2023
Q1 | USD 1.95 M | Vender |
12,267
-70
| -0.6% | -USD 10.7 k | 0.55% | 40 |
|
|
2022
Q4 | USD 1.99 M | Vender |
12,337
-675
| -5% | -USD 104 k | 0.59% | 40 |
|
|
2022
Q3 | USD 1.75 M | Vender |
13,012
-225
| -2% | -USD 32.3 k | 0.55% | 43 |
|
|
2022
Q2 | USD 2.03 M | Vender |
13,237
-2,075
| -14% | -USD 317 k | 0.62% | 42 |
|
|
2022
Q1 | USD 2.48 M | Vender |
15,312
-590
| -4% | -USD 85.7 k | 0.63% | 42 |
|
|
2021
Q4 | USD 2.15 M | Vender |
15,902
-10
| -0.1% | -USD 1.18 k | 0.52% | 43 |
|
|
2021
Q3 | USD 1.72 M | Vender |
15,912
-65
| -0.4% | -USD 7.43 k | 0.46% | 48 |
|
|
2021
Q2 | USD 1.8 M | Vender |
15,977
-120
| -0.7% | -USD 13.5 k | 0.48% | 49 |
|
|
2021
Q1 | USD 1.74 M | Vender |
16,097
-15
| -0.1% | -USD 1.6 k | 0.5% | 45 |
|
|
2020
Q4 | USD 1.73 M | Mantener |
16,112
| – | – | 0.51% | 46 |
|
|
2020
Q3 | USD 1.41 M | Comprar |
16,112
+1,257
| +8% | +USD 118 k | 0.45% | 49 |
|
|
2020
Q2 | USD 1.46 M | Vender |
14,855
-660
| -4% | -USD 58.1 k | 0.49% | 48 |
|
|
2020
Q1 | USD 1.18 M | Vender |
15,515
-10
| -0.1% | -USD 852 | 0.47% | 49 |
|
|
2019
Q4 | USD 1.38 M | Vender |
15,525
-925
| -6% | -USD 76.8 k | 0.45% | 51 |
|
|
2019
Q3 | USD 1.24 M | Vender |
16,450
-1,900
| -10% | -USD 130 k | 0.43% | 51 |
|
|
2019
Q2 | USD 1.33 M | Vender |
18,350
-725
| -4% | -USD 57 k | 0.47% | 49 |
|
|
2019
Q1 | USD 1.54 M | Vender |
19,075
-445
| -2% | -USD 36.4 k | 0.55% | 48 |
|
|
2018
Q4 | USD 1.8 M | Vender |
19,520
-935
| -5% | -USD 82.2 k | 0.76% | 42 |
|
|
2018
Q3 | USD 1.93 M | Vender |
20,455
-150
| -0.7% | -USD 14.2 k | 0.66% | 45 |
|
|
2018
Q2 | USD 1.91 M | Vender |
20,605
-750
| -4% | -USD 73.2 k | 0.7% | 44 |
|
|
2018
Q1 | USD 2.02 M | Vender |
21,355
-820
| -4% | -USD 90.1 k | 0.76% | 43 |
|
|
2017
Q4 | USD 2.14 M | Vender |
22,175
-4,710
| -18% | -USD 444 k | 0.78% | 42 |
|
|
2017
Q3 | USD 2.39 M | Vender |
26,885
-1,225
| -4% | -USD 93.3 k | 0.86% | 38 |
|
|
2017
Q2 | USD 2.04 M | Vender |
28,110
-450
| -2% | -USD 30.3 k | 0.75% | 44 |
|
|
2017
Q1 | USD 1.86 M | Vender |
28,560
-1,550
| -5% | -USD 97.4 k | 0.76% | 42 |
|
|
2016
Q4 | USD 1.89 M | Vender |
30,110
-55
| -0.2% | -USD 3.36 k | 0.82% | 39 |
|
|
2016
Q3 | USD 1.9 M | Vender |
30,165
-1,170
| -4% | -USD 75.7 k | 0.81% | 39 |
|
|
2016
Q2 | USD 1.94 M | Vender |
31,335
-175
| -0.6% | -USD 10.7 k | 0.82% | 41 |
|
|
2016
Q1 | USD 1.8 M | Comprar |
31,510
+1,775
| +6% | +USD 98.9 k | 0.78% | 44 |
|
|
2015
Q4 | USD 1.76 M | Comprar |
29,735
+2,510
| +9% | +USD 145 k | 0.79% | 44 |
|
|
2015
Q3 | USD 1.48 M | Vender |
27,225
-2,385
| -8% | -USD 155 k | 0.69% | 53 |
|
|
2015
Q2 | USD 1.99 M | Vender |
29,610
-100
| -0.3% | -USD 6.53 k | 0.85% | 43 |
|
|
2015
Q1 | USD 1.74 M | Vender |
29,710
-1,380
| -4% | -USD 83.4 k | 0.72% | 50 |
|
|
2014
Q4 | USD 2.03 M | Comprar |
31,090
+2,020
| +7% | +USD 127 k | 0.86% | 43 |
|
|
2014
Q3 | USD 1.68 M | Vender |
29,070
-260
| -0.9% | -USD 14.4 k | 0.75% | 45 |
|
|
2014
Q2 | USD 1.66 M | Comprar |
29,330
+360
| +1% | +USD 18.9 k | 0.76% | 44 |
|
|
2014
Q1 | USD 1.49 M | Mantener |
28,970
| – | – | 0.73% | 43 |
|
|
2013
Q4 | USD 1.53 M | Mantener |
28,970
| – | – | 0.76% | 42 |
|
|
2013
Q3 | USD 1.3 M | Vender |
28,970
-480
| -2% | -USD 21.3 k | 0.72% | 47 |
|
|
2013
Q2 | USD 1.22 M | Comprar |
+29,450
| Nuevas | +USD 1.29 M | 0.73% | 46 |
|
Otros fondos que tienen ABBV en su cartera
Posición de Brian C. Broderick en ABBV: resumen de T2 2026
Brian C. Broderick aumentó su participación en AbbVie (ABBV) en 1.3% durante T2 2026, al comprar aproximadamente USD 38.7 k y elevar la posición a 14,011 acciones con un valor de USD 3.53 M. La posición representa 0.55% de la cartera y ocupa el puesto #40.
Brian C. Broderick reportó por primera vez una posición en ABBV en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 4,238 fondos que sigue Wall St. Rank mantienen una posición en ABBV.
- Al cierre de T2 2026, Brian C. Broderick tenía 14,011 acciones de AbbVie con un valor de USD 3.53 M.
- Brian C. Broderick compró 180 acciones de AbbVie en T2 2026, por un monto estimado de USD 38.7 k.
- AbbVie representó 0.55% de la cartera de Brian C. Broderick en T2 2026 y fue su posición número 40.
- Brian C. Broderick reportó por primera vez una posición en AbbVie en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 4,238 fondos que sigue Wall St. Rank tenían AbbVie en cartera.
Según el Informe 13F de Brian C. Broderick correspondiente a T2 2026, presentado el 11 ago 2026.